Di Crosta, M.; Ragone, F.C.; Benedetti, R.; D’Orazi, G.; Santarelli, R.; Gilardini Montani, M.S.; Cirone, M.
Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells. Biomedicines 2025, 13, 2279.
https://doi.org/10.3390/biomedicines13092279
AMA Style
Di Crosta M, Ragone FC, Benedetti R, D’Orazi G, Santarelli R, Gilardini Montani MS, Cirone M.
Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells. Biomedicines. 2025; 13(9):2279.
https://doi.org/10.3390/biomedicines13092279
Chicago/Turabian Style
Di Crosta, Michele, Francesca Chiara Ragone, Rossella Benedetti, Gabriella D’Orazi, Roberta Santarelli, Maria Saveria Gilardini Montani, and Mara Cirone.
2025. "Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells" Biomedicines 13, no. 9: 2279.
https://doi.org/10.3390/biomedicines13092279
APA Style
Di Crosta, M., Ragone, F. C., Benedetti, R., D’Orazi, G., Santarelli, R., Gilardini Montani, M. S., & Cirone, M.
(2025). Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells. Biomedicines, 13(9), 2279.
https://doi.org/10.3390/biomedicines13092279
